• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌挽救性颈清扫术的临床结局与初始治疗、手术范围及患者因素的关系

Clinical outcome of salvage neck dissections in head and neck cancer in relation to initial treatment, extent of surgery and patient factors.

作者信息

van den Bovenkamp K, Noordhuis M G, Oosting S F, van der Laan B F A M, Roodenburg J L, Bijl H P, Halmos G B, Plaat B E C

机构信息

Department of Otorhinolaryngology/Head and Neck Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Clin Otolaryngol. 2017 Jun;42(3):693-700. doi: 10.1111/coa.12818. Epub 2017 Jan 24.

DOI:10.1111/coa.12818
PMID:28032952
Abstract

OBJECTIVE

Salvage surgery has a higher complication rate compared to primary surgical treatment. We evaluated clinical outcome of salvage neck dissections in relation to initial treatment modality, extent of surgery and patient-related factors.

DESIGN

Single institution consecutive case series.

SETTING

Tertiary Head and Neck Cancer Centre.

PARTICIPANTS

In all, 87 patients with head and neck squamous cell carcinoma, who underwent salvage neck dissection after initial radiotherapy (n = 30), radiotherapy with carboplatin/5-fluorouracil (n = 43) or radiotherapy with cetuximab (n = 14).

MAIN OUTCOME MEASURES

Incidence of complications, disease-specific survival.

RESULTS

Complications occurred in 28% of the patients. Multivariate analysis identified extent of neck dissection as the only independent predictor of surgical complications (P = 0.010). Surgical complication rate was 16% after radiotherapy with systemic treatment, and 47% after radiotherapy alone (P = 0.171). The 5-year disease-specific survival was 55%, independent of complications, initial treatment, extent of surgery and patient-related factors.

CONCLUSION

The only predictor for surgical complications was extent of surgery. Survival was not influenced by complications.

摘要

目的

挽救性手术与初次手术治疗相比,并发症发生率更高。我们评估了挽救性颈清扫术的临床结局与初始治疗方式、手术范围及患者相关因素之间的关系。

设计

单机构连续病例系列。

地点

三级头颈癌中心。

参与者

总共87例头颈部鳞状细胞癌患者,他们在初始放疗(n = 30)、放疗联合卡铂/5-氟尿嘧啶(n = 43)或放疗联合西妥昔单抗(n = 14)后接受了挽救性颈清扫术。

主要观察指标

并发症发生率、疾病特异性生存率。

结果

28%的患者发生了并发症。多因素分析确定颈清扫范围是手术并发症的唯一独立预测因素(P = 0.010)。全身治疗放疗后的手术并发症发生率为16%,单纯放疗后的手术并发症发生率为47%(P = 0.171)。5年疾病特异性生存率为55%,与并发症、初始治疗、手术范围及患者相关因素无关。

结论

手术并发症的唯一预测因素是手术范围。生存率不受并发症影响。

相似文献

1
Clinical outcome of salvage neck dissections in head and neck cancer in relation to initial treatment, extent of surgery and patient factors.头颈部癌挽救性颈清扫术的临床结局与初始治疗、手术范围及患者因素的关系
Clin Otolaryngol. 2017 Jun;42(3):693-700. doi: 10.1111/coa.12818. Epub 2017 Jan 24.
2
Outcomes in Advanced Head and Neck Cancer Treated with Up-front Neck Dissection prior to (Chemo)Radiotherapy.在(化疗)放疗前先行颈部清扫术治疗的晚期头颈癌的治疗结果。
Otolaryngol Head Neck Surg. 2016 Feb;154(2):300-8. doi: 10.1177/0194599815608370. Epub 2015 Oct 8.
3
Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.在先前接受过放疗的头颈癌挽救性手术后辅助立体定向体部放疗±西妥昔单抗。
Laryngoscope. 2014 Jul;124(7):1579-84. doi: 10.1002/lary.24441. Epub 2014 Apr 22.
4
Effectiveness of selective neck dissection in head and neck cancer: the experience of two Italian centers.选择性颈清扫术在头颈癌治疗中的有效性:两个意大利中心的经验。
Laryngoscope. 2015 Aug;125(8):1849-55. doi: 10.1002/lary.25296. Epub 2015 Apr 17.
5
Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.III期或IV期头颈部鳞状细胞癌患者接受器官保留治疗后的手术并发症比较。
Arch Otolaryngol Head Neck Surg. 1998 Apr;124(4):401-6. doi: 10.1001/archotol.124.4.401.
6
Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma.在声门上或下咽癌N2 - N3期器官保留方案中,在放化疗联合治疗前进行计划性颈部清扫术。
ORL J Otorhinolaryngol Relat Spec. 2012;74(2):64-9. doi: 10.1159/000333111. Epub 2012 Feb 9.
7
Viable tumor in salvage neck dissections in head and neck cancer: Relation with initial treatment, change of lymph node size and human papillomavirus.头颈部癌挽救性颈部清扫术中的存活肿瘤:与初始治疗、淋巴结大小变化和人乳头瘤病毒的关系。
Oral Oncol. 2018 Feb;77:131-136. doi: 10.1016/j.oraloncology.2017.12.017. Epub 2018 Jan 8.
8
Elective neck dissection for second primary after previous definitive radiotherapy.先前接受根治性放疗后,对第二原发肿瘤行选择性颈清扫术。
Am J Otolaryngol. 2012 Mar-Apr;33(2):199-204. doi: 10.1016/j.amjoto.2011.04.009.
9
Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.接受放化疗或生物放疗的头颈癌患者局部复发后的挽救性手术。
Auris Nasus Larynx. 2015 Apr;42(2):145-9. doi: 10.1016/j.anl.2014.10.002. Epub 2014 Nov 13.
10
[Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].[125例局部晚期头颈部鳞状细胞癌多模态治疗的疗效及预后因素]
Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):217-22.

引用本文的文献

1
Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk?头颈部鳞状细胞癌经(化疗)放疗后行挽救性颈清扫术后的并发症:哪些患者属于高危人群?
BMC Cancer. 2025 May 2;25(1):823. doi: 10.1186/s12885-025-14232-7.
2
Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary.对于患有晚期淋巴结疾病的头颈部鳞状细胞癌患者,在对其原发灶进行根治性(化疗)放疗时,颈部处理方面的进展及尚存的知识空白
Strahlenther Onkol. 2024 Jul;200(7):553-567. doi: 10.1007/s00066-024-02228-4. Epub 2024 Apr 10.
3
Opportunities and Limits in Salvage Surgery in Persistent or Recurrent Head and Neck Squamous Cell Carcinoma.
持续性或复发性头颈部鳞状细胞癌挽救性手术的机遇与局限
Cancers (Basel). 2021 May 18;13(10):2457. doi: 10.3390/cancers13102457.
4
A comparison of the Thunderbeat and standard electrocautery devices in head and neck surgery: a prospective randomized controlled trial.雷脉与标准电切设备在头颈部手术中的比较:一项前瞻性随机对照试验。
Eur Arch Otorhinolaryngol. 2021 Dec;278(12):4987-4996. doi: 10.1007/s00405-021-06739-z. Epub 2021 Mar 19.
5
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌临床管理的最新进展与未来方向
Cancers (Basel). 2021 Jan 18;13(2):338. doi: 10.3390/cancers13020338.
6
Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.糖蛋白非转移性黑色素瘤蛋白 B 作为治疗后转移性头颈部癌症的潜在影像学标志物。
Otolaryngol Head Neck Surg. 2020 Dec;163(6):1202-1208. doi: 10.1177/0194599820932869. Epub 2020 Jun 30.
7
Surgical nodal management in hypopharyngeal and laryngeal cancer.下咽癌和喉癌的外科淋巴结处理。
Eur Arch Otorhinolaryngol. 2020 May;277(5):1481-1489. doi: 10.1007/s00405-020-05838-7. Epub 2020 Feb 11.
8
Surgical rescue for persistent head and neck cancer after first-line treatment.一线治疗后持续性头颈部癌症的外科抢救。
Eur Arch Otorhinolaryngol. 2020 May;277(5):1437-1448. doi: 10.1007/s00405-020-05807-0. Epub 2020 Jan 25.
9
Elective neck dissection (END) and cN0 hard palate and upper gingival cancers: A National Cancer Database analysis of factors predictive of END and impact on survival.择区性颈清扫术(END)和 cN0 硬腭和上颌牙龈癌:国家癌症数据库分析预测 END 的因素及其对生存的影响。
J Surg Oncol. 2019 Dec;120(7):1259-1265. doi: 10.1002/jso.25706. Epub 2019 Sep 23.
10
Neck management in head and neck squamous cell carcinomas: where do we stand?头颈部鳞状细胞癌的颈部管理:我们处于什么位置?
Med Oncol. 2019 Mar 27;36(5):40. doi: 10.1007/s12032-019-1265-1.